Gene Editing;Gene Therapy;Blood Disorders;Sickle Cell Disease;lipid nanoparticles;Hematopoietic Stem Cells;hemoglobinopathies;immunodeficiencies;mRNA
-
Health News
CHOP and Penn Medicine Researchers Develop “In Vivo” RNA-based Gene Editing Model for Blood Disorders
[ad_1] Newswise — Philadelphia, July 27, 2023—In a step forward in the development of genetic medicines, researchers at Children’s Hospital…
Read More »